The submissions include 510(k) applications for indications covering general surgery.

Key Points Interested in Medtronic PLC? Here are five stocks we like better. Medtronic is on track to rebound in the back ...

Medtronic (MDT) stock gains as the company beats Q4 FY26 estimates thanks to the cardiovascular unit while its FY27 EPS ...

Medtronic (NYSE:MDT) has advanced U.S. expansion of its Hugo robotic assisted surgery system with new FDA filings and ...

Medtronic has undergone a business revamp and is now ready to grow again, including by leaning into acquisitions.

Medtronic (NYSE:MDT) today announced a strategic collaboration with Karl Storz to expand access to integrated ENT surgical ...

Medtronic’s MiniMed separation highlights portfolio reshaping, stronger revenue momentum, focused capital plans and renewed ...

Medtronic just wrapped up its best year in a decade.

Medtronic (NYSE:MDT) today shared new data demonstrating five-year outcomes with its Harmony transcatheter pulmonary valve ...

For the quarter, the Diabetes business delivered 15% reported growth or 8.1% organic, driven by strong international ...

Securing 510(k) authorization would position Medtronic to compete with Intuitive in major robotic surgery markets.

Medtronic acquire pain management devicemaker SPR Therapeutics for $650M to expand neuromodulation with peripheral nerve stimulation technology.